https://finance.yahoo.com/news/bionano-genome-mapping-platform-could-235053495.html

On Monday, the company disclosed that its genome mapping platform Saphyr has been accredited in the US by the College of American Pathologists. The platform will be used by Bionano’s customer Praxis Genomics, marking it as the first company to offer a laboratory developed test (LDT) utilizing whole genome analysis.

It is probably priced in and the price is already up about 400% in a month.

$BNGO